| LifeStance Names Vaughn Paunovich as Chief Technology Officer |
SCOTTSDALE, Ariz. , May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. |
prnewswire.com |
2025-05-14 13:00:00 |
Czytaj oryginał (ang.) |
| LifeStance Health Group, Inc. (LFST) Q1 2025 Earnings Call Transcript |
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q1 2025 Results Conference Call May 7, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ryan McGroarty - CFO David Bourdon - CEO Conference Call Participants Craig Hettenbach - Morgan Stanley Jamie Perse - Goldman Sachs Ryan Daniels - William Blair Brian Tanquilut - Jefferies Richard Close - Canaccord Genuity Dylan Christopher - UBS Steven Dechert - KeyBanc Capital Markets Operator Good day, everyone, and thank you for standing by. My name is Arji, and I will be your conference operator today. |
seekingalpha.com |
2025-05-10 18:22:02 |
Czytaj oryginał (ang.) |
| LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why |
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2025-05-08 17:05:37 |
Czytaj oryginał (ang.) |
| Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround |
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. |
zacks.com |
2025-05-08 14:35:45 |
Czytaj oryginał (ang.) |
| LifeStance Health Group (LFST) Reports Break-Even Earnings for Q1 |
LifeStance Health Group (LFST) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago. |
zacks.com |
2025-05-07 12:10:37 |
Czytaj oryginał (ang.) |
| LifeStance Reports First Quarter 2025 Results |
SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2025. |
globenewswire.com |
2025-05-07 10:00:00 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade |
The mean of analysts' price targets for LifeStance Health (LFST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
zacks.com |
2025-05-05 15:01:23 |
Czytaj oryginał (ang.) |
| LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release |
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-04-30 15:06:28 |
Czytaj oryginał (ang.) |
| LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion |
I remain bullish on LifeStance Health Group stock due to robust demand, clinician retention, and margin expansion potential, despite recent share price declines. LFST's flexible hybrid care model and digital check-in tool enhance clinician retention and patient accessibility, driving sustainable growth and competitive advantage. LFST's adjusted EBITDA margin reached 10.1% in 4Q24, with management targeting 15-20% over time, supported by operational efficiencies and higher-margin services. |
seekingalpha.com |
2025-04-22 10:12:26 |
Czytaj oryginał (ang.) |
| LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025 |
SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. |
globenewswire.com |
2025-04-21 20:10:00 |
Czytaj oryginał (ang.) |
| LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains? |
LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
zacks.com |
2025-04-10 16:40:50 |
Czytaj oryginał (ang.) |
| LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner |
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. |
zacks.com |
2025-03-21 12:55:35 |
Czytaj oryginał (ang.) |
| LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call Transcript |
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ken Burdick - CEO David Bourdon - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrea Alfonso - UBS Operator Thank you for standing by. My name is Danielle, and I will be your conference operator today. |
seekingalpha.com |
2025-02-28 11:31:33 |
Czytaj oryginał (ang.) |
| LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates |
LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.12 per share a year ago. |
zacks.com |
2025-02-27 10:35:25 |
Czytaj oryginał (ang.) |
| LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman |
Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz. , Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (Nasdaq: LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer. |
prnewswire.com |
2025-02-27 08:02:00 |
Czytaj oryginał (ang.) |
| LifeStance Reports Fourth Quarter and Full Year 2024 Results |
SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2024. |
globenewswire.com |
2025-02-27 08:00:00 |
Czytaj oryginał (ang.) |
| LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release |
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-02-20 13:05:32 |
Czytaj oryginał (ang.) |
| LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025 |
SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025. |
globenewswire.com |
2025-02-06 18:10:00 |
Czytaj oryginał (ang.) |
| Best Momentum Stocks to Buy for January 29th |
EAT, LFST and MC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 29, 2024. |
zacks.com |
2025-01-29 13:01:32 |
Czytaj oryginał (ang.) |
| New Strong Buy Stocks for January 29th |
MC, LFST, EAT, CYRX and HCP have been added to the Zacks Rank #1 (Strong Buy) List on January 29, 2024. |
zacks.com |
2025-01-29 09:16:08 |
Czytaj oryginał (ang.) |
| LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know |
LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). |
zacks.com |
2025-01-17 15:01:17 |
Czytaj oryginał (ang.) |
| Tenet Healthcare downgraded to Neutral from Buy at Goldman Sachs |
Goldman Sachs analyst Jamie Perse downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. For Tenet, the analyst sees policy risk "taking center stage" and likely leaving shares range bound until policy outcomes are better defined, reflected in out year estimates, and in the stock's valuation. |
https://thefly.com |
2024-12-16 07:18:38 |
Czytaj oryginał (ang.) |
| LifeStance upgraded to Buy from Neutral at Goldman Sachs |
Goldman Sachs upgraded LifeStance to Buy from Neutral with a $10 price target. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. The analyst believes LifeStance's continued operational execution will continue in 2025, and on an organic basis, Goldman's analysis suggests its EBITDA can grow 27% through 2027. |
https://thefly.com |
2024-12-16 07:17:36 |
Czytaj oryginał (ang.) |
| Universal Health downgraded to Neutral from Buy at Goldman Sachs |
Goldman Sachs downgraded Universal Health to Neutral from Buy with a price target of $198, down from $228. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on healthcare providers, the analyst tells investors in a research note. With this view, the firm downgraded hospitals Tenet (THC) and Universal Health (UHS) to Neutral while upgrading Lifestance Health Group (LFST) to Buy, where it believes the company is more insulated from policy risk. For Universal Health, the analyst sees policy risk "taking center stage" and likely leaving shares range bound until policy outcomes are better defined, reflected in out year estimates, and in the stock's valuation. |
https://thefly.com |
2024-12-16 07:16:25 |
Czytaj oryginał (ang.) |
| Lifeist Announces Reorganization of the Board of Directors |
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, today announced a reorganization of its Board of Directors. As part of Lifeist's ongoing efforts to enhance corporate governance and further strengthen its leadership structure, Meni Morim, a director of the Company and the former CEO of the Company, has been appointed Chairman of the Board, while Branden Spikes, a director of the Company, has transitioned to the role of Lead Independent Director. |
globenewswire.com |
2024-12-13 19:00:00 |
Czytaj oryginał (ang.) |
| Lifeist Announces the “Mikra Wellness Giveaway” Holiday Campaign |
TORONTO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") and a leader in science-driven health and wellness innovations, is launching a marketing initiative for the holiday season: The Mikra Wellness Giveaway. Mikra's latest campaign, designed to reward loyal customers and drive new customer acquisition, will run from today, December 9, 2024, to January 15, 2025, and include those purchases of Mikra's scientifically formulated supplements made on wearemikra.com. |
globenewswire.com |
2024-12-09 10:02:00 |
Czytaj oryginał (ang.) |
| Lifeist Appoints Andrea Judge as Chief Executive Officer and Joins the Board of Directors |
TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, is pleased to announce the appointment of Andrea Judge as Chief Executive Officer of Lifeist Wellness Inc. effective today. Andrea, the current CEO of Lifeist's subsidiary Mikra Cellular Sciences Inc. (“Mikra”) since July 2024, will now lead Lifeist in its entirety. |
globenewswire.com |
2024-11-21 09:01:00 |
Czytaj oryginał (ang.) |
| Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group |
New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge technology to transform the patient and family experience, and address physician burnout New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge technology to transform the patient and family experience, and address physician burnout |
globenewswire.com |
2024-11-20 11:00:00 |
Czytaj oryginał (ang.) |
| LifeStance Health Group, Inc. (LFST) Q3 2024 Earnings Call Transcript |
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Jack Senft - William Blair Jamie Perse - Goldman Sachs Stephanie Davis - Barclays Operator Thank you for standing by. My name is Liz and I'll be your conference operator today. |
seekingalpha.com |
2024-11-08 20:21:38 |
Czytaj oryginał (ang.) |
| LifeStance Health Group (LFST) Reports Q3 Loss, Tops Revenue Estimates |
LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.17 per share a year ago. |
zacks.com |
2024-11-07 10:15:22 |
Czytaj oryginał (ang.) |
| LifeStance Reports Third Quarter 2024 Results |
SCOTTSDALE, Ariz., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2024. |
globenewswire.com |
2024-11-07 08:00:00 |
Czytaj oryginał (ang.) |
| Lifeist Reports Third Quarter 2024 Financial Results |
TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for the three months ended August 31, 2024 (“Q3 2024”) compared to the same period last year (“Q3 2023”). All financial figures are in Canadian dollars unless otherwise indicated. |
globenewswire.com |
2024-10-30 09:10:00 |
Czytaj oryginał (ang.) |
| LifeStance to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024 |
SCOTTSDALE, Ariz., Oct. 17, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2024 earnings release before the market opens on Thursday, November 7, 2024. |
globenewswire.com |
2024-10-17 20:10:00 |
Czytaj oryginał (ang.) |
| Lifeist Announces Conclusion of Consulting Agreement with Singular Narrative Management Ltd. |
TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support wellness in innovative ways, today announced the termination of its consulting agreement with Singular Narrative Management Ltd. ("Singular") effective October 31, 2024. |
globenewswire.com |
2024-10-16 11:00:00 |
Czytaj oryginał (ang.) |
| LifeStance Survey Finds 79% of Americans Are Experiencing Anxiety Over the 2024 U.S. Presidential Election |
Election stress is contributing to an increase in anxiety and strained relationships, reinforcing the importance of accessible mental healthcare SCOTTSDALE, Ariz. , Oct. 8, 2024 /PRNewswire/ -- A LifeStance Health survey released today reveals how widespread election-related anxiety is impacting Americans' mental health, straining their personal relationships and prompting many to limit social media exposure. |
prnewswire.com |
2024-10-08 13:00:00 |
Czytaj oryginał (ang.) |
| Lifeist Closes CannMart Transaction with Simply Solventless Concentrates Ltd. |
TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support human wellness in innovative ways, is pleased to report that, further to its news release dated June 25, 2024, it has completed the sale today of the shares (the “Closing”) of CannMart Inc. (“CannMart”), a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards, to Simply Solventless Concentrates Ltd. |
globenewswire.com |
2024-09-12 22:11:00 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Think LifeStance Health (LFST) Could Surge 26.68%: Read This Before Placing a Bet |
The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
zacks.com |
2024-08-30 14:55:56 |
Czytaj oryginał (ang.) |
| Mikra Ships FOCUS Ahead of Schedule and Prepares for Marketing Push |
Six-time MLB All-Star, three-time Silver Slugger, and Olympic medal winner José Bautista Photo credit: Connor LaVigne TORONTO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") has begun shipping initial preorders of its new product, FOCUS. Developed in close collaboration with six-time MLB All-Star, three-time Silver Slugger and Olympic medal winner José Bautista, FOCUS combines a precision blend of citicoline, tyrosine and pure lion's mane mushroom to deliver improved memory, total concentration and faster cognition without any caffeine or stimulants. |
globenewswire.com |
2024-08-29 11:00:00 |
Czytaj oryginał (ang.) |
| Lifeist Wellness Chairman's Letter to Shareholders |
TORONTO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc.(TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF) My Fellow Shareholders, Further to my previous letter of August 15, 2024, we wish to remind you of the reasoning behind the strategic decision to divest Lifeist of CannMart Inc. (“CannMart”) via a sale to Simply Solventless Concentrates Ltd. (“SSC”) per our press release of June 25, 2024, and why shareholders should vote in favor of the transaction at the Annual and Special Meeting on September 5, 2024. |
globenewswire.com |
2024-08-28 11:00:00 |
Czytaj oryginał (ang.) |
| Mikra Engages impact.com for Partnerships Expansion |
TORONTO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, reports that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") has engaged the services of impact.com to deploy their award-winning partnership discovery, management and optimization platform. Partnerships and affiliate marketing are a key area of growth in the nutraceutical industry, and Mikra is committed to dramatically expanding its footprint in that space. |
globenewswire.com |
2024-08-27 11:00:00 |
Czytaj oryginał (ang.) |
| LifeStance Health Group: Long-Term Growth With Adj. EBITDA Margin Inflection Upwards |
LFST has a strong value proposition for patients and is well-positioned to grow due to the increasing demand for mental health services in the US. Recent positive financial results show improved revenue and adj EBITDA margins, giving confidence in LFST's ability to achieve double-digit margins by FY25. The hybrid model of in-person and telehealth services provides advantages for both patients and LFST, leading to increased patient adoption and potential for continued growth. |
seekingalpha.com |
2024-08-22 12:49:38 |
Czytaj oryginał (ang.) |